OTHER PUBLICATIONS

2017

Molimard M, Raherison C, Lignot S, Balestra A, Lamarque S, Chartier A, Droz-Perroteau C, Lassalle R, Moore N, Girodet PO. Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients. Eur Respir J. 2017 Feb 15;49(2) Http://dx.doi.org/10.1183/13993003.01794-2016

 

2016

Tashkin DP. A review of nebulized drug delivery in COPD. Int J Chron Obstruct Pulmon Dis. 2016 Oct 18;11:2585-2596 Http://dx.doi.org/10.2147/COPD.S114034

 

2015

Azouz W, Chetcuti P, Hosker HS, Saralaya D, Stephenson J, Chrystyn H. The inhalation characteristics of patients when they use different dry powder inhalers. J Aerosol Med Pulm Drug Deliv. 2015 Feb;28(1):35-42. Http://dx.doi.org/10.1089/jamp.2013.1119

Scichilone N, Benfante A, Bocchino M, Braido F, Paggiaro P, Papi A, Santus P, Sanduzzi A. Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases? Pulm Pharmacol Ther. 2015 Feb 24. Http://dx.doi.org/10.1016/j.pupt.2015.02.006

van Aalderen WM, Garcia-Marcos L, Gappa M, Lenney W, Pedersen S, Dekhuijzen R, Price D. How to match the optimal currently available inhaler device to an individual child with asthma or recurrent wheeze. NPJ Prim Care Respir Med. 2015 Jan 8;25:14088. Http://dx.doi.org/10.1038/npjpcrm.2014.88

Levy ML, Asthma deaths: what now? Winter R. Thorax. 2015 Mar;70(3):209-10. Http://dx.doi.org/10.1136/thoraxjnl-2015-206800

Leaker BR, Barnes PJ, Jones CR, Tutuncu A, Singh D. Efficacy and safety of nebulized glycopyrrolate for administration using a high efficiency nebulizer in patients with chronic obstructive pulmonary disease. Br J Clin Pharmacol. 2015 Mar;79(3):492-500. Http://dx.doi.org/10.1111/bcp.12517

Hochhaus G, Horhota S, Hendeles L, Suarez S, Rebello J. Pharmacokinetics of Orally Inhaled Drug Products. AAPS J. 2015 Mar 12. Http://dx.doi.org/10.1208/s12248-015-9736-6

Vanderman AJ, Moss JM, Bailey JC, Melnyk SD, Brown JN. Inhaler misuse in an older adult population. Consult Pharm. 2015;30(2):92-100. Http://dx.doi.org/10.4140/TCP.n.2015.92

 

2014

Molimard M, Colthorpe P. Inhaler Devices for Chronic Obstructive Pulmonary Disease: Insights from Patients and Healthcare Practitioners. J Aerosol Med Pulm Drug Deliv. 2014 Sep 29. Http://dx.doi.org/10.1089/jamp.2014.1142

Dekhuijzen PN, Bjermer L, Lavorini F, Ninane V, Molimard M, Haughney J. Guidance on handheld inhalers in asthma and COPD guidelines. Respir Med. 2014 May;108(5):694-700. Http://dx.doi.org/10.1016/j.rmed.2014.02.013

Chrystyn H, Small M, Milligan G, Higgins V, Gil EG, Estruch J. Impact of patients’ satisfaction with their inhalers on treatment compliance and health status in COPD. Respir Med. 2014 Feb;108(2):358-65. Http://dx.doi.org/10.1016/j.rmed.2013.09.021

Corradi M, Chrystyn H, Cosio BG, Pirozynski M, Loukides S, Louis R, Spinola M, Usmani OS. NEXThaler, an innovative dry powder inhaler delivering an extrafine fixed combination of beclometasone and formoterol to treat large and small airways in asthma. Expert Opin Drug Deliv. 2014 Sep;11(9):1497-506. Http://dx.doi.org/10.1517/17425247.2014.928282

Aggarwal B, Gogtay J. Use of pressurized metered dose inhalers in patients with chronic obstructive pulmonary disease: review of evidence. Expert Rev Respir Med. 2014 Jun;8(3):349-56. Http://dx.doi.org/10.1586/17476348.2014.905916

Lavorini F, Fontana GA, Usmani OS. New inhaler devices – the good, the bad and the ugly. Respiration. 2014;88(1):3-15. Http://dx.doi.org/10.1159/000363390

Vogelmeier C, Kardos P, Hofmann T, Canisius S, Scheuch G, Muellinger B, Nocker K, Menz G, Rabe KF. Nebulised budesonide using a novel device in patients with oral steroid-dependent asthma. Eur Respir J. 2014 Dec 10. Http://dx.doi.org/10.1183/09031936.00152014

Lavorini F. Inhaled drug delivery in the hands of the patient. J Aerosol Med Pulm Drug Deliv. 2014 Dec;27(6):414-8. Http://dx.doi.org/10.1089/jamp.2014.1132

Chawes BL, Govoni M, Kreiner-Møller E, Vissing NH, Poorisrisak P, Mortensen L, Nilsson E, Bisgaard A, Dossing A, Deleuran M, Skytt NL, Samandari N, Piccinno A, Sergio F, Ciurlia G, Poli G, Acerbi D, Singh D, Bisgaard H. Systemic exposure to inhaled beclometasone/formoterol DPI is age and body size dependent. Respir Med. 2014 Aug;108(8):1108-16. Http://dx.doi.org/10.1016/j.rmed.2014.05.007

Ninane V, Brusselle GG, Louis R, Dupont L, Liistro G, De Backer W, Schlesser M, Vincken W. Usage of inhalation devices in asthma and chronic obstructive pulmonary disease: a Delphi consensus statement. Expert Opin Drug Deliv. 2014 Mar;11(3):313-23. Http://dx.doi.org/10.1517/17425247.2014.872626

 

2013

Lavorini F, Usmani OS. Correct inhalation technique is critical in achieving good asthma control. Prim Care Respir J. 2013 Dec;22(4):385-6. Http://dx.doi.org/10.4104/pcrj.2013.00097

Smaldone G, Berkland C, Gonda I, Mitchell J, Usmani OS, Clark A. Ask the experts: the benefits and challenges of pulmonary drug delivery. Ther Deliv. 2013;4(8):905-13. Http://dx.doi.org/10.4155/tde.13.76

Lavorini F, Ninane V, Haughney J, Bjermer L, Molimard M, Dekhuijzen RP. Switching from branded to generic inhaled medications: potential impact on asthma and COPD. Expert Opin Drug Deliv. 2013;10(12):1597-602. Http://dx.doi.org/10.1517/17425247.2013.852182

Colthorpe P, Voshaar T, Kieckbusch T, Cuoghi E, Jauernig J. Delivery characteristics of a low-resistance dry-powder inhaler used to deliver the longacting muscarinic antagonist glycopyrronium. J Drug Assess 2013;2:11-6. Http://dx.doi.org/10.3109/21556660.2013.766197

Dekhuijzen PNR, Vincken W, Virchow JC, Roche N, Agusti A, Lavorini F, Van Aalderen WM, Price D. Prescription of inhalers in asthma and COPD: towards a rational, rapid and effective approach. Respir Med. 2013 Dec;107(12):1817-21. Http://dx.doi.org/10.1016/j.rmed.2013.09.013

 

2012

Matera MG, Calzetta L, Segreti A, Cazzola M. Emerging drugs for chronic obstructive pulmonary disease. Expert Opin Emerg Drugs. 2012 Mar;17(1):61-82. Http://dx.doi.org/10.1517/14728214.2012.660917

Capstick TG1, Clifton IJ. Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma. Expert Rev Respir Med. 2012;6(1):91-101; Http://dx.doi.org/10.1586/ers.11.89

Price D, Chrystyn H, Kaplan A, Haughney J, Román-Rodríguez M, Burden A, Chisholm A, Hillyer EV, von Ziegenweidt J, Ali M, van der Molen T. Effectiveness of same versus mixed asthma inhaler devices: a retrospective observational study in primary care. Allergy Asthma Immunol Res. 2012;4(4):184-91. Http://dx.doi.org/10.4168/aair.2012.4.4.184

Usmani OS. Treating the small airways. Respiration. 2012;84(6):441-53. Http://dx.doi.org/10.1159/000343629
Friebel C, Steckel H, Müller BW. Rational design of a dry powder inhaler: device design and optimisation. J Pharm Pharmacol. 2012 Sep;64(9):1303-15. Http://dx.doi.org/10.1111/j.2042-7158.2012.01525.x

Plaza V, Sanchis J, Roura P, Molina J, Calle M, Quirce S, Viejo JL, Caballero F, Murio C. Physicians’ knowledge of inhaler devices and inhalation techniques remains poor in Spain. J Aerosol Med Pulm Drug Deliv. 2012;25(1):16-22. Http://dx.doi.org/10.1089/jamp.2011.0895

 

2011

Dolovich MB, Dhand R. Aerosol drug delivery: developments in device design and clinical use. Lancet. 2011 Mar 19;377(9770):1032-45. Http://dx.doi.org/10.1016/S0140-6736(10)60926-9

Laube BL, Janssens HM, de Jongh FH, Devadason SG, Dhand R, Diot P, Everard ML, Horvath I, Navalesi P, Voshaar T, Chrystyn H; European Respiratory Society; International Society for Aerosols in Medicine. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J 2011;37:1308-31. Http://dx.doi.org/10.1183/09031936.00166410

Hardwell A, Barber V, Hargadon T, McKnight E, Holmes J, Levy ML. Technique training does not improve the ability of most patients to use pressurised metered-dose inhalers (pMDIs). Prim Care Respir J. 2011;20(1):92-6. Http://dx.doi.org/10.4104/pcrj.2010.00088

Dalby RN, Eicher J, Zierenberg B. Development of Respimat® Soft MistTM inhaler and its clinical utility in respiratory disorders. Med Devices Auckl 2011;4:145-55. Http://dx.doi.org/10.2147/MDER.S7409

Corrigan CJ. Asthma therapy: there are guidelines, and then there is real life…. Prim Care Respir J. 2011 Mar;20(1):13-4. Http://dx.doi.org/10.4104/pcrj.2011.00016

 

2010

De Backer W, Devolder A, Poli G, Acerbi D, Monno R, Herpich C, Sommerer K, Meyer T, Mariotti F. Lung deposition of BDP/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients. J Aerosol Med Pulm Drug Deliv. 2010;23(3):137-48. Http://dx.doi.org/10.1089/jamp.2009.0772

Doyle S, Lloyd A, Williams A, Chrystyn H, Moffat M, Thomas M, Price D. What happens to patients who have their asthma device switched without their consent? Prim Care Respir J. 2010;19(2):131-9. Http://dx.doi.org/10.4104/pcrj.2010.00009